Severity of Chronic Kidney Disease as a Risk Factor for Operative Mortality in Nonemergent Patients in the California Coronary Artery Bypass Graft Surgery Outcomes Reporting Program

Khung Keong Yeo, Zhongmin Li, Jane Y Yeun, Ezra A Amsterdam

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Guidelines published by the National Kidney Foundation in 2002 categorize renal failure into 5 stages of increasing severity. The relation of this classification to risk stratification for operative mortality in patients with nonemergent coronary artery bypass grafting (CABG) has not been clarified. We examined the effect of chronic kidney disease (CKD) severity on CABG operative mortality in patients with nonemergent CABG. Data reporting to the California CABG outcomes reporting program is mandated in California. Data from 121 hospitals on patients undergoing CABG in 2003 and 2004 were analyzed, including clinical characteristics, CKD stage, and operative mortality. CKD stage 1 and 2 were combined to form the reference group because data on urinary markers of renal failure were not available. Excluding patients with emergent or salvage acuity for CABG, 37,735 isolated CABGs were performed. Of these, 27,132 patients (71.9%) had glomerular filtration rate (GFR) ≥60 ml/min/1.73 m2; 8,861 (23.5%) had stage 3 CKD (GFR 30 to 59); 669 (1.8%) had stage 4 CKD (GFR 15 to 29); and 1,073 (2.8%) had stage 5 CKD (GFR <15 or on dialysis). In separate multivariate analyses, GFR and CKD stage were each significantly and independently associated with operative mortality (both p <0.0001). Operative mortality increased significantly with each stage of CKD (all p <0.01). Compared with the reference group, stage 3, (odds ratio [OR] 1.18, p = 0.0374), stage 4 (OR 2.23, p <0.0001), and stage 5 (OR 4.39, p <0.0001) had increasingly higher operative mortality. In conclusion, CKD stage based on National Kidney Foundation guidelines is an important predictor in risk stratification for operative mortality in patients undergoing nonemergent CABG.

Original languageEnglish (US)
Pages (from-to)1269-1274
Number of pages6
JournalAmerican Journal of Cardiology
Volume101
Issue number9
DOIs
StatePublished - May 1 2008

Fingerprint

Chronic Renal Insufficiency
Coronary Artery Bypass
Transplants
Mortality
Glomerular Filtration Rate
Odds Ratio
Renal Insufficiency
Guidelines
Kidney
Dialysis
Research Design
Multivariate Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{bec3d50283c440918ff4bf77d4d1a272,
title = "Severity of Chronic Kidney Disease as a Risk Factor for Operative Mortality in Nonemergent Patients in the California Coronary Artery Bypass Graft Surgery Outcomes Reporting Program",
abstract = "Guidelines published by the National Kidney Foundation in 2002 categorize renal failure into 5 stages of increasing severity. The relation of this classification to risk stratification for operative mortality in patients with nonemergent coronary artery bypass grafting (CABG) has not been clarified. We examined the effect of chronic kidney disease (CKD) severity on CABG operative mortality in patients with nonemergent CABG. Data reporting to the California CABG outcomes reporting program is mandated in California. Data from 121 hospitals on patients undergoing CABG in 2003 and 2004 were analyzed, including clinical characteristics, CKD stage, and operative mortality. CKD stage 1 and 2 were combined to form the reference group because data on urinary markers of renal failure were not available. Excluding patients with emergent or salvage acuity for CABG, 37,735 isolated CABGs were performed. Of these, 27,132 patients (71.9{\%}) had glomerular filtration rate (GFR) ≥60 ml/min/1.73 m2; 8,861 (23.5{\%}) had stage 3 CKD (GFR 30 to 59); 669 (1.8{\%}) had stage 4 CKD (GFR 15 to 29); and 1,073 (2.8{\%}) had stage 5 CKD (GFR <15 or on dialysis). In separate multivariate analyses, GFR and CKD stage were each significantly and independently associated with operative mortality (both p <0.0001). Operative mortality increased significantly with each stage of CKD (all p <0.01). Compared with the reference group, stage 3, (odds ratio [OR] 1.18, p = 0.0374), stage 4 (OR 2.23, p <0.0001), and stage 5 (OR 4.39, p <0.0001) had increasingly higher operative mortality. In conclusion, CKD stage based on National Kidney Foundation guidelines is an important predictor in risk stratification for operative mortality in patients undergoing nonemergent CABG.",
author = "Yeo, {Khung Keong} and Zhongmin Li and Yeun, {Jane Y} and Amsterdam, {Ezra A}",
year = "2008",
month = "5",
day = "1",
doi = "10.1016/j.amjcard.2008.01.002",
language = "English (US)",
volume = "101",
pages = "1269--1274",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Severity of Chronic Kidney Disease as a Risk Factor for Operative Mortality in Nonemergent Patients in the California Coronary Artery Bypass Graft Surgery Outcomes Reporting Program

AU - Yeo, Khung Keong

AU - Li, Zhongmin

AU - Yeun, Jane Y

AU - Amsterdam, Ezra A

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Guidelines published by the National Kidney Foundation in 2002 categorize renal failure into 5 stages of increasing severity. The relation of this classification to risk stratification for operative mortality in patients with nonemergent coronary artery bypass grafting (CABG) has not been clarified. We examined the effect of chronic kidney disease (CKD) severity on CABG operative mortality in patients with nonemergent CABG. Data reporting to the California CABG outcomes reporting program is mandated in California. Data from 121 hospitals on patients undergoing CABG in 2003 and 2004 were analyzed, including clinical characteristics, CKD stage, and operative mortality. CKD stage 1 and 2 were combined to form the reference group because data on urinary markers of renal failure were not available. Excluding patients with emergent or salvage acuity for CABG, 37,735 isolated CABGs were performed. Of these, 27,132 patients (71.9%) had glomerular filtration rate (GFR) ≥60 ml/min/1.73 m2; 8,861 (23.5%) had stage 3 CKD (GFR 30 to 59); 669 (1.8%) had stage 4 CKD (GFR 15 to 29); and 1,073 (2.8%) had stage 5 CKD (GFR <15 or on dialysis). In separate multivariate analyses, GFR and CKD stage were each significantly and independently associated with operative mortality (both p <0.0001). Operative mortality increased significantly with each stage of CKD (all p <0.01). Compared with the reference group, stage 3, (odds ratio [OR] 1.18, p = 0.0374), stage 4 (OR 2.23, p <0.0001), and stage 5 (OR 4.39, p <0.0001) had increasingly higher operative mortality. In conclusion, CKD stage based on National Kidney Foundation guidelines is an important predictor in risk stratification for operative mortality in patients undergoing nonemergent CABG.

AB - Guidelines published by the National Kidney Foundation in 2002 categorize renal failure into 5 stages of increasing severity. The relation of this classification to risk stratification for operative mortality in patients with nonemergent coronary artery bypass grafting (CABG) has not been clarified. We examined the effect of chronic kidney disease (CKD) severity on CABG operative mortality in patients with nonemergent CABG. Data reporting to the California CABG outcomes reporting program is mandated in California. Data from 121 hospitals on patients undergoing CABG in 2003 and 2004 were analyzed, including clinical characteristics, CKD stage, and operative mortality. CKD stage 1 and 2 were combined to form the reference group because data on urinary markers of renal failure were not available. Excluding patients with emergent or salvage acuity for CABG, 37,735 isolated CABGs were performed. Of these, 27,132 patients (71.9%) had glomerular filtration rate (GFR) ≥60 ml/min/1.73 m2; 8,861 (23.5%) had stage 3 CKD (GFR 30 to 59); 669 (1.8%) had stage 4 CKD (GFR 15 to 29); and 1,073 (2.8%) had stage 5 CKD (GFR <15 or on dialysis). In separate multivariate analyses, GFR and CKD stage were each significantly and independently associated with operative mortality (both p <0.0001). Operative mortality increased significantly with each stage of CKD (all p <0.01). Compared with the reference group, stage 3, (odds ratio [OR] 1.18, p = 0.0374), stage 4 (OR 2.23, p <0.0001), and stage 5 (OR 4.39, p <0.0001) had increasingly higher operative mortality. In conclusion, CKD stage based on National Kidney Foundation guidelines is an important predictor in risk stratification for operative mortality in patients undergoing nonemergent CABG.

UR - http://www.scopus.com/inward/record.url?scp=43049126123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049126123&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2008.01.002

DO - 10.1016/j.amjcard.2008.01.002

M3 - Article

C2 - 18435956

AN - SCOPUS:43049126123

VL - 101

SP - 1269

EP - 1274

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -